Pharmacopsychiatry

Issue 02 · Volume 52 · February 2019 DOI: 10.1055/s-009-42493

Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP) and Deutsche Gesellschaft für Biologische Psychiatrie (DGBP)
Abstracts of the 1st Symposium of the Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP) and Deutsche Gesellschaft für Biologische Psychiatrie (DGBP)
Seminaris Campus Hotel Berlin, Germany, 06.–08.03.2019

Editors: Manfred Gerlach, Würzburg; Jürgen Deckert, Würzburg; Sabine Herpertz, Heidelberg; Jens Wiltfang, Göttingen

Abstracts (HTML) List of Authors

P4 Neuroimaging

P4.1

Lückel, M; Benedyk, A; Kessler, R; Jansen, A: Resting-state functional network connectivity is altered in patients with major depressive disorder

Abstract
HTML

P4.2

Benedyk, A; Lückel, M; Kessler, R; Jansen, A: Altered functional resting-state connectivity in schizophrenia and bipolar disorder patients

Abstract
HTML

P4.3

Stein, F; Lemmer, G; Schmitt, S; Brosch, K; Fischer, E; Meller, T; Nagels, A; Nenadic, I; Dannlowski, U; Kircher, T; Krug, A: The relationship of symptom dimensions and grey matter volume in a transdiagnostic cohort: Results from the DFG FOR2107

Abstract
HTML

P4.4

Meller, T; Schmitt, S; Stein, F; Brosch, K; Dannlowski, U; Krug, A; Kircher, T; Nenadic, I: Morphometric correlates of subclinical schizotypal signs and schizophrenia nuclear symptoms in healthy subjects: Results from the DFG FOR2107

Abstract
HTML